Celcuity (CELC) Enterprise Value (2016 - 2025)
Celcuity (CELC) posted Enterprise Value of -$717.3 million for Q4 2025, down 57.66% on a QoQ basis from -$455.0 million in Q3 2025, and down 205.1% year-over-year from $682.5 million in Q4 2024.
Celcuity (CELC) Enterprise Value (2016 - 2025) Analysis & Trends
Celcuity's Enterprise Value history runs 10 years deep, the most recent figure standing at -$717.3 million for Q4 2025.
- Quarterly Enterprise Value fell 205.1% year-over-year to -$717.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$717.3 million (down 205.1% YoY) and the FY2025 annual result came in at -$717.3 million, down 205.1% from the prior year.
- Enterprise Value was -$717.3 million for Q4 2025 at Celcuity, down from -$455.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$35.0 million in Q1 2021 and bottomed at -$717.3 million in Q4 2025.
- A 5-year average of -$187.4 million and a median of -$162.9 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value slumped 623.06% — and 2025, when it jumped 40.51%.
- Celcuity's Enterprise Value stood at -$84.3 million in 2021, then tumbled by 99.97% to -$168.6 million in 2022, then retreated by 7.12% to -$180.6 million in 2023, then slumped by 30.19% to -$235.1 million in 2024, then tumbled by 205.1% to -$717.3 million in 2025.
- Business Quant data shows CELC's Enterprise Value at -$717.3 million in Q4 2025, -$455.0 million in Q3 2025, and -$168.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Celcuity | 3.89 Bn | 3.89 Bn | - | -717.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -717.30 Mn |
| Sep 30, 2025 | -454.98 Mn |
| Jun 30, 2025 | -168.39 Mn |
| Mar 31, 2025 | -205.69 Mn |
| Dec 31, 2024 | -235.10 Mn |
| Sep 30, 2024 | -264.06 Mn |
| Jun 30, 2024 | -283.07 Mn |
| Mar 31, 2024 | -177.66 Mn |
| Dec 31, 2023 | -180.58 Mn |
| Sep 30, 2023 | -133.94 Mn |
| Jun 30, 2023 | -146.24 Mn |
| Mar 31, 2023 | -157.48 Mn |
| Dec 31, 2022 | -168.59 Mn |
| Sep 30, 2022 | -57.51 Mn |
| Jun 30, 2022 | -66.93 Mn |
| Mar 31, 2022 | -78.32 Mn |
| Dec 31, 2021 | -84.31 Mn |
| Sep 30, 2021 | -90.39 Mn |
| Jun 30, 2021 | -41.66 Mn |
| Mar 31, 2021 | -34.96 Mn |